Figure 2From: Native human autoantibodies targeting GIPC1 identify differential expression in malignant tumors of the breast and ovary Reactivity of 27.B1 (A) and 27.F7 (B) against SK-BR-3. Fluorescence intensity of tumor cells incubated with myeloma IgM (1), 27.B1 (A-2), and 27.F7 (B-2) demonstrate positive cell-surface reactivity against the breast carcinoma cell line, SK-BR-3.Back to article page